Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.

× No keyword cloud information.

3 in total

Review 1. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors: D A Mankoff; F Dehdashti; A F Shields
Journal: Neoplasia Date: 2000 Jan-Apr Impact factor: 5.715

Review 2. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

Authors: John A Katzenellenbogen
Journal: Cancers (Basel) Date: 2020-07-23 Impact factor: 6.639

3. [¹⁸F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

Authors: Marina Orevi; Ofer Shamni; Nomi Zalcman; Alexandre Chicheportiche; Anat Mordechai; Samuel Moscovici; Yigal Shoshan; Tal Shahar; Hanna Charbit; Mijal Gutreiman; Iddo Paldor; Eyal Mishani; Alexander Lossos; Iris Lavon
Journal: Neurooncol Adv Date: 2021-01-29

3 in total

Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.

Review 1. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Review 2. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

3. [18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

3. [¹⁸F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.